Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Robert E. Corringham0
Joyce K. James0
Patrick B. O'Donnell0
Date of Patent
January 31, 2017
0Patent Application Number
144892900
Date Filed
September 17, 2014
0Patent Primary Examiner
Patent abstract
Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients, including a specific patient population. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
